Sanofi
SNY
SNY
486 hedge funds and large institutions have $8.53B invested in Sanofi in 2018 Q1 according to their latest regulatory filings, with 53 funds opening new positions, 157 increasing their positions, 181 reducing their positions, and 67 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
13% less repeat investments, than reductions
Existing positions increased: 157 | Existing positions reduced: 181
21% less first-time investments, than exits
New positions opened: 53 | Existing positions closed: 67
22% less funds holding in top 10
Funds holding in top 10: 9 → 7 (-2)
Holders
486
Holding in Top 10
7
Calls
$56.6M
Puts
$21.3M
Top Buyers
| 1 | +$23M | |
| 2 | +$21.9M | |
| 3 | +$21.1M | |
| 4 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$19.5M |
| 5 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
+$18.7M |
Top Sellers
| 1 | -$364M | |
| 2 | -$94.6M | |
| 3 | -$68.4M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$66.8M |
| 5 |
Morgan Stanley
New York
|
-$36M |